| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.044 | 6.199 | 6.602 | 5.983 | 5.867 | 6.037 | 7.419 | 7.564 | 14.475 | 24.898 |
| Total Income - EUR | 1.044 | 6.199 | 6.602 | 5.983 | 5.867 | 6.037 | 7.419 | 7.564 | 14.475 | 24.898 |
| Total Expenses - EUR | 282 | 5.164 | 4.462 | 3.005 | 2.632 | 2.800 | 8.355 | 3.653 | 3.929 | 14.934 |
| Gross Profit/Loss - EUR | 762 | 1.035 | 2.141 | 2.978 | 3.235 | 3.236 | -936 | 3.911 | 10.546 | 9.965 |
| Net Profit/Loss - EUR | 730 | 849 | 1.943 | 2.798 | 3.058 | 3.068 | -1.154 | 3.688 | 8.958 | 8.136 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio Simbol Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 807 | 1.827 | 3.800 | 6.422 | 6.574 | 9.520 | 1.393 | 2.720 | 9.909 | 13.955 |
| Inventories | 0 | 24 | 0 | 0 | 0 | 184 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 508 | 5.229 | 6.571 | 6.587 | 606 | 608 | 1.486 | 9.126 |
| Cash | 807 | 1.803 | 3.292 | 1.194 | 3 | 2.749 | 786 | 2.112 | 8.423 | 4.829 |
| Shareholders Funds | 775 | 1.616 | 3.532 | 6.265 | 6.419 | 9.365 | 1.137 | 2.579 | 9.331 | 13.045 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 31 | 211 | 268 | 158 | 155 | 154 | 256 | 141 | 578 | 910 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3312 - 3312" | |||||||||
| CAEN Financial Year |
3312
|
|||||||||
Comments - Bio Simbol Srl